首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Thoracic Oncology

Journal Of Thoracic Oncology杂志,由International Association for the Study of Lung Cancer出版,于2006年创刊,Monthly,出版语言English,ISSN:1556-0864,E-ISSN:1556-1380。

投稿咨询
Journal Of Thoracic Oncology
Journal Of Thoracic Oncology
Journal Of Thoracic Oncology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
23.3
CiteScore
33.4
期刊收录
SCI、SCIE

Journal Of Thoracic Oncology(中文译名:《胸部肿瘤学杂志》),ISSN:1556-0864,EISSN:1556-1380,是International Association for the Study of Lung Cancer出版的国际性学术期刊,创刊于2006年,以Monthly形式稳定发行,2026年总发文量约108篇。该刊采用非OA开放访问,学科归属为医学 - 呼吸系统。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达23.3,2025年期刊CiteScore为33.4,2025年期刊自引率约4.3%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Journal Of Thoracic Oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期一般,3-6周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、Japan、Canada、England、Spain、Italy等为核心发文国家与地区;UNIVERSITY OF TEXAS SYSTEMHARVARD UNIVERSITY、MEMORIAL SLOAN KETTERING CANCER CENTER、UNIVERSITY OF TORONTO、UNIVERSITY OF CALIFORNIA SYSTEM、UNICANCER、SHANGHAI JIAO TONG UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学 RESPIRATORY SYSTEM 呼吸系统
1区 1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学 RESPIRATORY SYSTEM 呼吸系统
1区 1区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学 RESPIRATORY SYSTEM 呼吸系统
1区 1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 15 / 333

95.6

学科:RESPIRATORY SYSTEM SCIE Q1 3 / 107

97.7

学科:ONCOLOGY SCIE Q1 13 / 333

96.25

学科:RESPIRATORY SYSTEM SCIE Q1 4 / 107

96.73

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 13 / 328

96.2

学科:RESPIRATORY SYSTEM SCIE Q1 3 / 108

97.7

学科:ONCOLOGY SCIE Q1 13 / 328

96.19

学科:RESPIRATORY SYSTEM SCIE Q1 4 / 108

96.76


中国学者近期发文

1
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact (vol 21, pg 41, 2026

Author:Carbone, Michele; Amos, Christopher; Attanoos, Richard L.; Boeri, Mattia; Bueno, Raphael; Bunn, Paul A.; Chirieac, Lucian R.; Cooper, Benjamin; Fennell, Dean; Galateau-Salle, Francoise; Giannakou, Lydia; Goparaju, Chandra, V; Hassan, Raffit; Hofman, Paul; Kris, Mark G.; Mao, Weimin; Minaai, Michael; Mitsudomi, Tsetsuya; Molina, Thierry J.; Montuenga, Luis M.; Nabeshima, Kazuki; Passaro, Antonio; Peters, Solange; Rajan, Arun; Richardson, David B.; Robbins, Hilary; Rolfo, Christian; Rudin, Charles M.; Samet, Jonathan M.; Scherpereel, Arnaud; Schrump, David S.; Sozzi, Gabriella; Taioli, Emanuela; Visona, Silvia D.; Yang, Haining; Yoshikawa, Yoshie; Zhao, An; Pass, Harvey I

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 4, pp. -. DOI: 10.1016/j.jtho.2026.103576

2
GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinom

Author:Zhang, Xiaoshen; Wen, Yaokai; Wu, Fengying; Jiang, Yu; Lin, Yuechun; Wang, Lei; Zhou, Fei; Shen, Yue; Min, Zhen; Li, Wei; Liang, Wenhua; He, Jianxing; Zhou, Caicun

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.10.001

3
Neoadjuvant Immunochemotherapy in Resectable NSCLC With SMARCA4 Alteration

Author:Peng, Li-Shan; Cui, Qian; Zhang, Chao; Lin, Jun-Tao; Wu, You; Kang, Jin; Xu, Zi-Yi; Wang, Xiang-Yang; Cao, Ying-Jiao; Zhang, Qing-Ling; Wu, Yi-Long; Hu, Zheng; Zhong, Wen-Zhao

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.10.013

4
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON Stud

Author:Yang, Jin-Ji; Mu, Yu; Wang, Zhe-Hai; Duan, Jian-Chun; Zhang, Yan; Wu, Lin; Zhong, Hua; Zhao, Jun; Yao, Yu; Wang, Ping; Li, Xiao-Ling; Yang, Run-Xiang; Min, Xu-Hong; Lv, Dong-Qing; Xu, Hai-Peng; Fu, Zhen-Ming; Shen, Bo; Sun, Long-Hua; Wang, Chang-Li; Zhou, Jian-Ya; Xu, Rui-Lian; Ma, Hui-Wen; Zhao, Yan-Qiu; Shi, He-Peng; Zhang, Pei-Long; Xue, Wei-Zhe; Han, Di; Zheng, Yi; Wu, Yi-Long

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.11.008

5
Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommitte

Author:Zhu, Hongcheng; Al Saifi, Said; Bahig, Houda; Cooper, Alissa; Abrao, Fernando Conrado; Corrales, Luis; Faivre-Finn, Corinne; Filippi, Andrea Riccardo; Fitzgerald, Bailey; Khosla, Divya; Lam, Vincent K.; Le, Xiuning; Menezes, Vanessa; Newsom-Davis, Tom; Qin, Angel; Putora, Paul Martin; Munoz-Schuffenegger, Pablo; Siva, Shankar; Yu, Nathan Y.; Louie, Alexander, V

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.11.006

6
Response to Letter to the Editor: Refining Immunochemoradiotherapy for Patients With NSCLC and Brain Metastases: Insights on Biomarkers, Neuroprotection, and Global Applicabilit

Author:Li, Yang-Si; Yang, Jin-Ji; Wu, Yi-Long

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 335-336. DOI: 10.1016/j.jtho.2025.08.023

7
A Game-Changing 20 Years: Progress and Future Directions in Lung Cancer Screenin

Author:Lam, Stephen; Baldwin, David R.; Devaraj, Anand; Field, John; Henschke, Claudia I.; Heuvelmans, Marjolein A.; Huber, Rudolf M.; Jones, Catherine; Borondy-Kitts, Andrea; Li, Molly Siu Ching; Myers, Renelle; Osarogiagbon, Raymond U.; Robbins, Hilary A.; Tammemagi, Martin C.; Taylor, Kathryn L.; Triphuridet, Natthaya; Williams, Randi M.; Yankelevitz, David

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 235-252. DOI: 10.1016/j.jtho.2025.11.017

8
A Grading System for Resected Invasive Squamous Cell Carcinoma of the Lung: A Multi-Institutional Study by the IASLC Pathology Committe

Author:Mino-Kenudson, Mari; Berezowska, Sabina; Minami, Yuko; Chen, Shuyan; Ray, Meredith A.; Rerkpichaisuth, Vilasinee; Hashisako, Mikiko; Losmanova, Tereza; Hayashi, Takuo; Shim, Hyo-Sup; Righi, Luisella; Gagne, Andreanne; Kim, Tae-Jung; Bubendorf, Lukas; Lopez-Rios, Fernando; Matsubara, Daiske; Von Der Thusen, Jan; Lantuejoul, Sylvie; Roden, Anja C.; Nicholson, Andrew; Jain, Deepali; Han, Yuchen; Wynes, Murry W.; Dacic, Sanja; Smeltzer, Mathew P.; Cooper, Wendy A.; Papotti, Mauro G

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 294-309. DOI: 10.1016/j.jtho.2025.09.1761

9
The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database (vol 20, pg 1423, 2025

Author:Carbone, David P.; Hirsch, Fred R.; Osarogiagbon, Raymond Uyiosa; Nishimura, Katherine K.; Tsao, Ming Sound; Travis, William D.; Yang, Dawei; Yang, Soo-Ryum; Yatabe, Yasushi; Araujo, Luiz Henrique; Detterbeck, Frank; Lechtenberg, Kendra J.; Lim, Eric; Mack, Philip C.; Matilla, Jose-Maria; Montuenga, Luis M.; Nicholson, Andrew G.; Suda, Kenichi; Terra, Ricardo M.; Rami-Porta, Ramon; Asamura, Hisao; Rusch, Valerie; Wynes, Murry W

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 342-342. DOI:

10
Fine Particulate Matter (PM2.5) as a Driver of Genomic Alterations and Lung Tumour Initiatio

Author:Wang, P.; Naso, J.; Myers, R.; Durney, C. H.; Bartolomeu, C.; Mcguire, A.; Macaulay, C.; Lam, S.; Lam, W. L.; Lockwood, W. W

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 1, pp. -. DOI:


在线咨询

Journal Of Thoracic Oncology

国际简称:J THORAC ONCOL参考译名:胸部肿瘤学杂志

年发文量:108 CiteScore:33.4 是否预警:否 Gold OA文章占比:27.60% 研究类文章占比:93.52%

杂志社联系方式:LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621

Journal Of Thoracic Oncology